Agios Pharmaceuticals reports Q3 2023 revenue rise, progresses in clinical trials
Agios Pharmaceuticals Inc (NASDAQ:AGIO) has reported an increase in revenue for Q3 2023, despite a net loss. The company’s net…
Agios Pharmaceuticals Inc (NASDAQ:AGIO) has reported an increase in revenue for Q3 2023, despite a net loss. The company’s net…
(Reuters) – The Bank of England held interest rates at a 15-year peak on Thursday and said it did not…
(Reuters) – Duke Energy Corp on Thursday beat Wall Street estimates for third-quarter profit, with the company pointing to higher…
(Reuters) – The Federal Trade Commission in new court documents said Amazon.com (NASDAQ:AMZN) deliberately raised prices by more than $1…
(Reuters) – Uber (NYSE:UBER) and Lyft (NASDAQ:LYFT) will pay a combined $328 million to settle claims by New York’s attorney…
(Reuters) – The U.S. Securities and Exchange Commission on Thursday adopted new rules governing security-based swap trading platforms, implementing a…
(Reuters) – Moderna on Thursday said its 2023 sales would only hit the low end of its $6 billion to…
A consortium of Swiss financial institutions is set to revolutionize digital financial markets through the launch of Helvetia Phase III,…
E-Commerce software platform Shopify (NYSE:SHOP) reported Q3 FY2023 results topping analysts’ expectations, with revenue up 25.5% year on year to…
(Reuters) – Japan’s SoftBank (TYO:9984) Corp’s bond-type shares were listed on the Tokyo Stock Exchange on Thursday in the first…